INNsight articles by Peter Wittner, Interpharm Consultancy


Peter has been in the pharmaceutical industry for 30 years of which the second half has been mainly in the areas of generics.
 
He has worked for the former Evans Medical and then Norton Pharmaceuticals (now part of IVAX) where he was responsible for European Sales & Marketing. After leaving Norton Peter set up his own consultancy in 1993 and operated independently until 1996 when he joined the Indian company Ranbaxy to set up the infrastructure of their new UK subsidiary and spent two years with them.

For the last 7 years he has been back doing consultancy and specialising in the field of generics. You can contact Peter by email or see his website www.interpharm-consultancy.co.uk




Peter's INNsight articles
(To register for GenericsWeb's free monthly newsletter 'INNsight', click here)

10/01/07: Biosimilars - inflated expectations?
12/12/06: Germany - rising costs
15/11/06: Spain - a work in progress
12/10/06: The consolidation continues - part II
15/09/06: Generics as R&D experts
12/06/06: The story so far

10/05/06: US generics - evolution or revolution?
10/04/06: European generics - steaming ahead or grinding to a halt?
01/03/06: Authorised generics - what are they?
01/02/06: Asia – the next big thing in generics – but at what price?
01/01/06: A shaky future for US companies?
01/12/05: CPhI then and now
25/09/05: Generics then and now
28/08/05: Teva - a case ctudy
27/07/05: The consolidation continues
26/05/05: Europe - The generics pricing squeeze
25/04/05: Europe - The North-South divide
14/03/05: Generics superheroes
28/02/05: A Passage to India?

 
Contact Us | Terms and Conditions | Privacy Policy | Copyright GenericsWeb 2016